15353-j-veluchamy

28 | Chapter 1 26. Kondo E, Koda K, Takiguchi N, Oda K, Seike K, Ishizuka M, et al. Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer. Digestive surgery (2003) 20 (5):445-51. Epub 2003/08/06. doi: 72714. PubMed PMID: 12900537. 27. Ishigami S, Natsugoe S, Tokuda K, NakajoA, Che X, IwashigeH, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer (2000) 88 (3):577-83. Epub 2000/01/29. PubMed PMID: 10649250. 28. Villegas FR, Coca S, Villarrubia VG, Jimenez R, Chillon MJ, Jareno J, et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung cancer (Amsterdam, Netherlands) (2002) 35 (1):23-8. Epub 2001/12/26. PubMed PMID: 11750709. 29. Burke S, Lakshmikanth T, Colucci F, Carbone E. New views on natural killer cell-based immunotherapy for melanoma treatment. Trends in immunology (2010) 31 (9):339-45. Epub 2010/07/27. doi: 10.1016/j.it.2010.06.003. PubMed PMID: 20655806. 30. Ghiringhelli F, Menard C, Martin F, Zitvogel L. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunological reviews (2006) 214 :229-38. Epub 2006/11/15. doi: 10.1111/j.1600-065X.2006.00445.x. PubMed PMID: 17100888. 31. Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology (Baltimore, Md) (2009) 50 (3):799-807. Epub 2009/06/25. doi: 10.1002/hep.23054. PubMed PMID: 19551844. 32. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12 (4):253-68. Epub 2012/03/23. doi: 10.1038/nri3175. PubMed PMID: 22437938; PubMed Central PMCID: PMCPMC3587148. 33. Gill S, Vasey AE, De Souza A, Baker J, Smith AT, Kohrt HE, et al. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Blood (2012) 119 (24):5758-68. Epub 2012/05/01. doi: 10.1182/ blood-2012-03-415364. PubMed PMID: 22544698; PubMed Central PMCID: PMCPMC3382935. 34. Schafer JL, Müller-Trutwin MC, Reeves RK. NK cell exhaustion: bad news for chronic disease? Oncotarget (2015) 6 (26):21797-8. PubMed PMID: PMC4673125. 35. Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest (2011) 121 . doi: 10.1172/jci45816. 36. Bauernhofer T, Kuss I, Henderson B, Baum AS, Whiteside TL. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. European journal of immunology (2003) 33 (1):119- 24. Epub 2003/02/21. doi: 10.1002/immu.200390014. PubMed PMID: 12594840. 37. Parkhurst MR, Riley JP, Dudley ME, Rosenberg SA. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clinical cancer research : an official journal of the American Association for Cancer Research (2011) 17 (19):6287-97. Epub 2011/08/17. doi: 10.1158/1078-0432.ccr-11-1347. PubMed PMID: 21844012; PubMed Central PMCID: PMCPmc3186830.